SageView Advisory Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Buy
3,186
+427
+15% +$37.4K 0.01% 502
2026
Q1
$235K Buy
2,759
+1,075
+64% +$95.8K 0.01% 535
2025
Q4
$133K Buy
+1,684
New +$132K ﹤0.01% 733
2025
Q3
Sell
-8,160
Closed -$706K 647
2025
Q2
$706K Sell
8,160
-239
-3% -$21.8K 0.03% 302
2025
Q1
$787K Buy
+8,399
New +$752K 0.03% 260

Other funds holding CL

SageView Advisory Group's CL Position: Q2 2026 in Review

SageView Advisory Group increased its Colgate-Palmolive (CL) stake by 15% in Q2 2026, buying an estimated $37.4K and bringing the position to 3,186 shares worth $292K. The position accounts for 0.01% of the portfolio, ranked #502.

SageView Advisory Group first reported a position in CL in Q1 2025 and has held it in 5 quarters since. The position peaked at $787K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • SageView Advisory Group held 3,186 shares of Colgate-Palmolive worth $292K as of Q2 2026.
  • SageView Advisory Group bought 427 Colgate-Palmolive shares in Q2 2026, an estimated $37.4K.
  • Colgate-Palmolive made up 0.01% of SageView Advisory Group's portfolio in Q2 2026, its #502 holding.
  • SageView Advisory Group first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 5 quarters since.
  • SageView Advisory Group's Colgate-Palmolive position peaked at $787K in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on SageView Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.